0
Other Articles |

MANGANESE COMPOUNDS FOR CUTANEOUS DISEASES, COCCOGENIC INFECTIONS AND BLOOD FORMATION NOT ACCEPTABLE FOR NEW AND NONOFFICIAL REMEDIES

JAMA. 1940;114(3):248-249. doi:10.1001/jama.1940.62810030008012a.
Text Size: A A A
Published online

ABSTRACT

Manganese preparations proposed for the treatment of various cutaneous diseases (pustular acne, acne vulgaris, furunculosis, psoriasis, acne rosacea and sycosis vulgaris), coccogenic infections in general and for favorable effect on blood formation have long been marketed by many pharmaceutic manufacturers. Manganese butyrate 1 per cent solution has been the most universal parenteral preparation marketed for use in the treatment of the pustular dermatoses and deep seated coccic infections. Two firms (Mallinckrodt Chemical Works and Swan-Myers & Co.) submitted such a preparation to the Council fifteen years ago, at which time consideration was postponed for lack of acceptable evidence of its therapeutic usefulness. In all this time there has not been received from either of these two firms, or from any other firm marketing manganese butyrate, the additional evidence required by the Council. Swan-Myers & Co. has now been absorbed by Abbott Laboratories, which markets the compound under the name Mangatrate.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();